Black Rock Inc. Castle Biosciences Inc Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Black Rock Inc. holds 2,595,687 shares of CSTL stock, worth $56.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,595,687

Previous 2,283,199 13.69%

Holding current value

$56.5 Million

Previous $49.3 Million 16.69%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$18.06 - $25.3 $5.64 Million - $7.91 Million	312,488 Added 13.69%	2,595,687 $57.5 Million
Q4 2023 Feb 13, 2024	BUY	$12.19 - $22.43 $1.79 Million - $3.3 Million	147,019 Added 6.88%	2,283,199 $49.3 Million
Q3 2023 Nov 13, 2023	BUY	$13.28 - $20.3 $59,494 - $90,944	4,480 Added 0.21%	2,136,180 $36.1 Million
Q2 2023 Aug 11, 2023	BUY	$11.66 - $26.0 $141,587 - $315,718	12,143 Added 0.57%	2,131,700 $29.2 Million
Q1 2023 May 12, 2023	SELL	$19.47 - $28.49 $80,430 - $117,692	-4,131 Reduced 0.19%	2,119,557 $48.2 Million

Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $1.48 Million - $2.46 Million	81,864 Added 4.01%	2,123,688 $50 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $395,478 - $602,968	17,569 Added 0.87%	2,041,824 $53.3 Million
Q2 2022 Aug 12, 2022	BUY	$16.0 - $45.99 $3.87 Million - $11.1 Million	241,717 Added 13.56%	2,024,255 $44.4 Million
Q1 2022 May 12, 2022	SELL	$33.17 - $46.98 $625,221 - $885,526	-18,849 Reduced 1.05%	1,782,538 $80 Million
Q4 2021 Feb 10, 2022	BUY	$39.06 - $67.58 $1.77 Million - $3.07 Million	45,379 Added 2.58%	1,801,387 $77.2 Million
Q3 2021 Nov 09, 2021	BUY	$60.13 - $77.6 $3.85 Million - $4.97 Million	64,010 Added 3.78%	1,756,008 $117 Million
Q2 2021 Aug 11, 2021	BUY	$50.07 - $76.78 $84.7 Million - $130 Million	1,691,998 New	1,691,998 $124 Million

Others Institutions Holding CSTL

# of Institutions

162

Shares Held

25.3M

Call Options Held

82.2K

Put Options Held

150K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $572M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account